Ads
related to: medications for brain atrophy
Search results
Results From The WOW.Com Content Network
Cerebral atrophy is a common feature of many of the diseases that affect the brain. [1] ... but four months after treatment the brain was seemingly normal again.
However, a CT study in 1987 found no evidence of cerebral atrophy in prescribed benzodiazepine users. [ 72 ] In 1989, in a 4- to 6-year follow-up study of 30 inpatient people who used benzodiazepines non-medically, Neuropsychological function was found to be permanently affected in some people with long-term high dose non-medical use of ...
Cerebral aneurysm; Cerebral arteriosclerosis; Cerebral atrophy; Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy; Cerebral dysgenesis–neuropathy–ichthyosis–keratoderma syndrome; Cerebral gigantism; Cerebral palsy; Cerebral vasculitis; Cerebrospinal fluid leak; Cervical spinal stenosis; Charcot ...
In a mouse study, researchers found that zolpidem (Ambien), a common sleep aid, could prevent the brain from effectively clearing up 'waste', though it remains unclear whether this could affect ...
Anti-amyloid drugs also cause brain shrinkage. [296] The cholinesterase inhibitor benzgalantamine was approved by the FDA in July 2024. [297] Specific medications that may reduce the risk or progression of Alzheimer's disease have been studied. [298]
“The brain does not swell but continues to undergo atrophy no matter how many plaques it has. Future medications should aim at increasing Aβ42 directly, not indirectly such as what these ...
In addition to orthostatic hypotension, supine hypertension, where the BP is excessively high lying down, is a frequent problem in multiple system atrophy. Treatment of one symptom can easily aggravate the other, and supine hypertension in such patients has been linked to the same cardiovascular complications as essential hypertension. [73]
Cerebral small vessel disease is a heterogeneous condition involving damage to the small blood vessels in the brain, leading to brain tissue damage and atrophy of the brain structures.